Delivra Health Brands Inc. (TSX-V:DHB, OTCQB:DHBUF, FRA:3F0) said on Friday it has appointed John Barrett as a director, adding a former senior executive from major consumer goods companies as the health and wellness products maker looks to its next phase of growth. Barrett previously held senior roles at Frito-Lay and PepsiCo and served as chief commercial officer for Pernod Ricard USA.
PepsiCo announced a multi-year collaboration with Siemens and Nvidia designed to transform plant and supply chain operations through advanced digital twin technology and artificial intelligence (AI). The initiative positions the global consumer packaged goods giant at the forefront of industrial AI adoption for complex manufacturing and logistics systems.
Over the past decade, PepsiCo stock (NYSE; PEP) has solidified its status as a premier "cash cow" for investors, deploying a staggering $73 billion toward shareholder returns through a disciplined combination of consistent dividend growth and aggressive share buybacks.
PepsiCo has a 3.85% dividend yield to Coca-Cola's 2.84% It is growing that dividend at a much faster rate than Coca-Cola. PepsiCo also has superior cash flow metrics to its biggest rival.
Dividend Kings underperformed SPY in 2025, averaging 4.91% total return versus SPY's 17.72%, though 14 Kings outperformed the index. 2026 began strongly for Dividend Kings, up 4.66% through January 23rd, outpacing SPY's 1.07% gain. Nineteen Dividend Kings appear both potentially undervalued and offer long-term annualized expected returns of at least 10%.
Enterprise Products Partners is a strategic bet on oil's continued dominance, with a hefty 6.69% yield. T. Rowe Price is a storied financial services company with solid financials and a 40-year dividend growth streak.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.